ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008